All USA & Canada articles – Page 11
-
NewsScientists probe honeybee antiviral defense mechanisms
Scientists are investigating honeybee antiviral defense mechanisms with the goal of developing strategies to reduce honeybee colony deaths.
-
NewsNIH-funded clinical trial will evaluate new dengue therapeutic
A clinical trial is testing an experimental treatment designed to help people suffering the effects of dengue. An investigational therapeutic will be administered to adult volunteers who have been exposed to a weakened strain that causes a mild form of the disease.
-
NewsGene found in rough Salmonella Infantis variant offers drug target for variety of pathogens
A new study identifies a gene in a rough Salmonella Infantis variant that could offer a target for developing effective vaccines and therapeutic strategies, not only for Salmonella but other Enterobacteriaceae as well.
-
NewsWhy you shouldn’t scratch an itchy rash: New study explains
New research uncovers how scratching aggravates inflammation and swelling in a mouse model of a type of eczema called allergic contact dermatitis.
-
NewsAntibody treatment prevents severe bird flu in monkeys
A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, a new study reports.
-
News New tool can detect fast-spreading SARS-COV-2 variants before they take off
By analysing millions of viral genome sequences from around the world, a team of scientists has uncovered the specific mutations that give SARS-CoV-2 a ‘turbo boost’ in its ability to spread.
-
NewsFungal protein yields new ways to modulate cell activity remotely
A new study introduces tools that remotely and non-invasively communicate with and control the activity of engineered cells once they’ve entered the body. It focuses on a fungal protein the team have developed called Melt, which can be toggled by temperature.
-
NewsPapers outline 4 advances for inactivating infectious viruses and bacteria
Four papers provide insights into novel antiviral compounds and methods to inactivate infectious viral particles and bacteria.
-
NewsStudy finds three new safe, effective ways to treat drug-resistant tuberculosis
An international clinical trial has found three new safe and effective drug regimens for tuberculosis that is resistant to rifampin, the most effective of the first-line antibiotics used to treat TB.
-
NewsResearchers identify genetic ‘fingerprint’ to predict drug resistance in bacteria
To avoid antibiotic overuse and allow precise bacterial infection treatment, particularly against bacteria with multidrug resistance, a diagnostic tool was developed that identifies the pattern of DNA repair deficiencies acting as the bacterial antibiotic resistance ‘fingerprint’.
-
NewsTB or not TB? A new clinician decision support tool for tuberculosis
A risk assessing tool was recently developed to evaluate the likelihood of tuberculosis (TB) infections using previous patient data with or without TB. Such clinical decision support tool would allow safer and more efficient patient deisolation procedures and ensure smoother clinician workflows.
-
NewsCould faecal microbiota transplantation help patients heal after stem cell transplantation?
A study, from a part of an ongoing clinical trial, has reported the safety of oral faecal microbiota transplantation (FMT) to help patients recover from the loss of gut microbiome after allogeneic stem cell transplantation for blood cancers.
-
NewsMicrobial therapy offers new hope for vitiligo patients
A natural compound derived from gut-friendly bacteria significantly slows the progression of vitiligo and may restore pigmentation, reports a new pre-clinical study in mice.
-
NewsWhite blood cell count could predict severity of COVID-19 symptoms
A new study suggests that a readily available and inexpensive clinical marker of inflammation could be key in predicting debilitating COVID outcomes in postmenopausal women.
-
NewsMost Americans favor school vaccination requirements, but support is rising for opt-out options
A new survey finds that nearly three-quarters of U.S. adults support requiring that children be vaccinated against preventable diseases such as measles, mumps, and rubella.
-
NewsCARB-X funds Rhode Island Hospital to assess feasibility of direct from blood detection of bacterial pneumonia
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award Rhode Island Hospital at Brown University Health US$1M to demonstrate proof-of-concept of a polymerase chain reaction (PCR) approach informed by RNA sequencing to detect bacterial pneumonia directly from whole blood.
-
NewsScientists reveals how tiny algae shaped the evolution of giant clams
Scientists have sequenced the genome of the most widespread species of giant clam, Tridacna maxima, to reveal how these creatures adapted their genome to coexist with algae living inside them.
-
NewsFrom Fox News to MSNBC: Diverse media diet linked to higher trust in vaccines
People who get their news from an ideologically diverse array of sources are more likely to get vaccinated, regardless of their political affiliation, new research shows.
-
NewsHigh uric acid levels - and harmful gut bacteria - linked to deadly outcomes in children with severe malaria
Researchers have uncovered a significant connection between elevated uric acid levels and life-threatening outcomes in children with severe malaria. The study identified hyperuricemia as a potential contributor to increased mortality and long-term neurodevelopmental challenges in children with severe malaria.
-
OpinionReproductive biology though the lens of the microbiome
Madangchanok Imchen and Seth R. Bordenstein from the One Health Microbiome Center - winner of AMI’s WH Pierce Prize 2024 - explore the potential of the reproductive microbiome, particularly the fascinating Wolbachia, to counter global disease threats.